Dermatology NewsCV risk biomarkers tentatively identified in psoriatic diseaseMarch 11, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsDrug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsOne-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic ArthritisPsoriasisMixed Topics
An Update on JAK Inhibitors in Skin DiseaseMarch 3, 2022Atopic DermatitisPsoriasisPsoriatic Arthritis
Dermatology NewsHow to make the most of your time with psoriasis patientsFebruary 9, 2022PsoriasisPsoriatic Arthritis
Concurrent Atopic Dermatitis and Psoriasis Vulgaris: Implications for Targeted Biologic TherapyFebruary 4, 2022PsoriasisAtopic Dermatitis
Adjunctive Use of Halobetasol Propionate–Tazarotene in Biologic-Experienced Patients With PsoriasisFebruary 4, 2022Psoriasis
Severe Acute Systemic Reaction After the First Injections of IxekizumabFebruary 2, 2022Psoriatic ArthritisHair & NailsPsoriasis
Dermatology NewsA dermatologist-led model for CVD prevention in psoriasis may be feasibleFebruary 1, 2022PsoriasisPsoriatic Arthritis
Dermatology NewsMore frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022PsoriasisPsoriatic ArthritisMixed Topics
Dermatology NewsProactive infliximab monitoring found best for sustaining control of inflammatory diseasesJanuary 10, 2022Psoriatic ArthritisPsoriasis
Dermatology NewsCase series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasisJanuary 4, 2022PsoriasisRare DiseasesPsoriatic Arthritis
Dermatology NewsFDA to review PDE4-inhibitor roflumilast for psoriasisDecember 30, 2021PsoriasisPediatrics
